
Zynerba Pharmaceuticals ZYNE
Quarterly report 2023-Q2
added 05-16-2026
Zynerba Pharmaceuticals Operating Cycle 2011-2026 | ZYNE
Annual Operating Cycle Zynerba Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 14.6 K | - | 182 K | 467 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 182 K | 467 | 65.7 K |
Operating Cycle of other stocks in the Drug manufacturers industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Cumberland Pharmaceuticals
CPIX
|
662 | $ 5.47 | 11.18 % | $ 81.3 M | ||
|
Evoke Pharma
EVOK
|
55.1 | - | - | $ 36.6 M | ||
|
AcelRx Pharmaceuticals
ACRX
|
117 | - | 7.5 % | $ 6.35 M | ||
|
DURECT Corporation
DRRX
|
653 | - | - | $ 50.1 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
121 | - | 0.86 % | $ 117 M | ||
|
Aerie Pharmaceuticals
AERI
|
576 | - | - | $ 754 M | ||
|
Agile Therapeutics
AGRX
|
146 | - | 10.11 % | $ 58.2 M | ||
|
Alimera Sciences
ALIM
|
181 | - | - | $ 142 M | ||
|
Cronos Group
CRON
|
61.7 | $ 2.63 | -4.01 % | $ 1.01 B | ||
|
Harrow Health
HROW
|
153 | $ 31.21 | 1.13 % | $ 1.15 B | ||
|
Athenex
ATNX
|
247 | - | -23.39 % | $ 1.76 M | ||
|
Avadel Pharmaceuticals plc
AVDL
|
416 | - | - | $ 2.06 B | ||
|
Catalent
CTLT
|
152 | - | - | $ 11.5 B | ||
|
HEXO Corp.
HEXO
|
775 | - | 2.45 % | $ 38.1 M | ||
|
Eagle Pharmaceuticals
EGRX
|
214 | - | -39.89 % | $ 27.7 M | ||
|
Endo International plc
ENDP
|
180 | - | - | $ 28.9 M | ||
|
Organogenesis Holdings
ORGO
|
106 | $ 2.41 | -6.95 % | $ 305 M | ||
|
Bausch Health Companies
BHC
|
78.9 | $ 5.42 | -0.55 % | $ 1.98 B | ||
|
Pacira BioSciences
PCRX
|
246 | $ 22.64 | -3.78 % | $ 1.05 B | ||
|
Canopy Growth Corporation
CGC
|
230 | $ 1.04 | -2.8 % | $ 112 M | ||
|
Tilray
TLRY
|
222 | $ 5.32 | -3.27 % | $ 3.29 B | ||
|
Aurora Cannabis
ACB
|
1.45 K | $ 3.32 | -0.9 % | $ 182 M | ||
|
Sonoma Pharmaceuticals
SNOA
|
182 | $ 1.09 | -7.63 % | $ 1.35 M | ||
|
Jupiter Wellness
JUPW
|
132 | - | - | $ 33.6 M | ||
|
Lannett Company
LCI
|
210 | - | 1.15 % | $ 7.11 M | ||
|
OrganiGram Holdings
OGI
|
2.92 K | $ 1.07 | -1.83 % | $ 102 M | ||
|
Evolus
EOLS
|
134 | $ 6.5 | -1.22 % | $ 419 M | ||
|
Veru
VERU
|
271 | $ 2.11 | 0.96 % | $ 30.9 M | ||
|
Emergent BioSolutions
EBS
|
237 | $ 7.94 | -3.29 % | $ 407 M | ||
|
ProPhase Labs
PRPH
|
141 | - | - | $ 5.07 M | ||
|
Radius Health
RDUS
|
239 | - | - | $ 1.42 B | ||
|
cbdMD
YCBD
|
152 | $ 0.77 | -6.44 % | $ 3.1 M | ||
|
Assertio Holdings
ASRT
|
590 | $ 23.32 | - | $ 149 M | ||
|
PetIQ
PETQ
|
108 | - | 1.64 % | $ 400 M | ||
|
Recro Pharma
REPH
|
112 | - | -4.76 % | $ 65.3 M | ||
|
OptiNose
OPTN
|
508 | - | - | $ 1.08 B | ||
|
SCYNEXIS
SCYX
|
2.74 | $ 0.74 | -4.0 % | $ 37 M | ||
|
PLx Pharma
PLXP
|
113 | - | -27.8 % | $ 2.56 M | ||
|
Viatris
VTRS
|
221 | $ 16.48 | -4.52 % | $ 19.2 B | ||
|
Zomedica Corp.
ZOM
|
218 | - | -0.21 % | $ 98 M | ||
|
Rockwell Medical
RMTI
|
72.5 | $ 0.79 | -0.55 % | $ 28.4 M | ||
|
China Pharma Holdings
CPHI
|
187 | $ 1.04 | -16.13 % | $ 4.46 M | ||
|
TherapeuticsMD
TXMD
|
3.34 K | $ 2.0 | 0.5 % | $ 23.1 M |